Also trades as UGS.SI.
ULG.SI
Strong BuyUnloved QualityAI neutralUltraGreen.ai Limited · Healthcare · Singapore · $672M
$0.57 +4.6% · close 6 Oct · scored 7 Oct
Unloved Quality: Strong and cheap; the market has not turned yet.
Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
UltraGreen.ai supplies indocyanine green, a fluorescence imaging agent used to guide surgery, along with related imaging software. It reported a 53% year-on-year rise in first-half earnings and declared its first interim dividend after a high-profile Singapore listing. Insiders bought about 0.12% of shares in the past 90 days, and the company has repurchased about 0.26%, which is encouraging. Quality and value scores are high. The listing history is short, though, and price momentum has faded since the IPO, so the durability of its position in the ICG market is not yet proven.
ABOUT ULTRAGREEN.AI LIMITED
Read
UltraGreen.ai Limited manufactures and sells Indocyanine Green (ICG) pharmaceutical products in the United States and internationally. It provides diagnostic imaging analytics and software solutions.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 49.2M | 72.0M | 108.0M | 137.9M | 41.0% | 158.5M | 170.0M | 194.6M | 18.8% |
| EPS | 0.02 | 0.03 | 0.05 | 0.19 | 107.3% | 0.06 | 0.08 | 0.09 | -32.2% |
| Shares | 1.1B | 1.1B | 1.1B | 1.1B | 0.0% | 1.1B | — | — | — |
| Debt | 26.9M | 34.2M | 152.3M | 3.1M | -51.1% | 5.0M | — | — | — |
| Equity | 55.5M | 83.3M | -26.0M | 310.6M | 77.6% | — | — | — | — |
| Op CF | 23.7M | 25.5M | 54.3M | 53.3M | 31.0% | 53.6M | — | — | — |
| Inv CF | -1.6M | -21.3M | -14.9M | 13.0M | — | — | — | — | — |
| Fin CF | -6.5M | -11.7M | -42.4M | 95.8M | — | — | — | — | — |
Swung more than 80% of stocks we rank over the past year (66% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ULG.SI are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ULG.SI | UltraGreen.ai Limited(you) | $672M | 92 | Strong Buy |
| AP4.SI | Riverstone Holdings Limited | $903M | 95 | Strong Buy |
| BSL.SI | Raffles Medical Group Ltd | $1.2B | 74 | Buy |
| FHH.SI | Foundation Healthcare Holdings Limited | $628M | 62 | Hold |
| 5WA.SI | OUE Healthcare Limited | $167M | 88 | Strong Buy |
| 1J5.SI | Hyphens Pharma International Limited | $88M | 100 | Strong Buy |
| QC7.SI | Q & M Dental Group (Singapore) Limited | $371M | 48 | Hold |
| ANL | Adlai Nortye Group Ltd. | $1.0B | 40 | Hold |
| 42C.SI | iX Biopharma Ltd. | $504M | 34 | Sell |
| H02.SI | Haw Par Corporation Limited | $2.3B | 51 | Hold |
Peer medians: ROE -0.2% · P/E 19.5x · Gross margin 41.1%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.